Journal of Biomedical Science (Aug 2023)

A novel phage carrying capsule depolymerase effectively relieves pneumonia caused by multidrug-resistant Klebsiella aerogenes

  • Xiaohu Cui,
  • Bing Du,
  • Junxia Feng,
  • Yanling Feng,
  • Zheng Fan,
  • Jinfeng Chen,
  • Jinghua Cui,
  • Lin Gan,
  • Tongtong Fu,
  • Ziyan Tian,
  • Rui Zhang,
  • Chao Yan,
  • Hanqing Zhao,
  • Wenjian Xu,
  • Ziying Xu,
  • Zihui Yu,
  • Zanbo Ding,
  • Zhoufei Li,
  • Yujie Chen,
  • Guanhua Xue,
  • Jing Yuan

DOI
https://doi.org/10.1186/s12929-023-00946-y
Journal volume & issue
Vol. 30, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background Klebsiella aerogenes can cause ventilator-associated pneumonia by forming biofilms, and it is frequently associated with multidrug resistance. Phages are good antibiotic alternatives with unique advantages. There has been a lack of phage therapeutic explorations, kinetic studies, and interaction mechanism research targeting K. aerogenes. Methods Plaque assay, transmission electron microscopy and whole-genome sequencing were used to determine the biology, morphology, and genomic characteristics of the phage. A mouse pneumonia model was constructed by intratracheal/endobronchial delivery of K. aerogenes to assess the therapeutic effect of phage in vivo. Bioinformatics analysis and a prokaryotic protein expression system were used to predict and identify a novel capsule depolymerase. Confocal laser scanning microscopy, Galleria mellonella larvae infection models and other experiments were performed to clarify the function of the capsule depolymerase. Results A novel lytic phage (pK4-26) was isolated from hospital sewage. It was typical of the Podoviridae family and exhibited serotype specificity, high lytic activity, and high environmental adaptability. The whole genome is 40,234 bp in length and contains 49 coding domain sequences. Genomic data show that the phage does not carry antibiotic resistance, virulence, or lysogenic genes. The phage effectively lysed K. aerogenes in vivo, reducing mortality and alleviating pneumonia without promoting obvious side effects. A novel phage-derived depolymerase was predicted and proven to be able to digest the capsule, remove biofilms, reduce bacterial virulence, and sensitize the bacteria to serum killing. Conclusions The phage pK4-26 is a good antibiotic alternative and can effectively relieve pneumonia caused by multidrug-resistant K. aerogenes. It carries a depolymerase that removes biofilms, reduces virulence, and improves intrinsic immune sensitivity.

Keywords